Another recent study investigating breast and colon carcinoma models found that CSF-1/CSF-1R signaling inhibition stimulated the expansion of neo-epitope-specific T cells and promoted the development of an immune-permissive TME [54]. This evidence concerns the gene CSF1 and colon carcinoma.